A report system for pet assessment of myocardial viability

Nuclear Medicine Communications

Volumn 20, Issue 10, 1999, Pages 895-899

  Lorenzoni, R ^a   Pagano, D ^a   Boyd, H ^a   Camici, Paolo ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT; SURGICAL RISK; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0032758322     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199910000-00005     Document Type: Article

References (23)

1. Yusuf S, Zucher D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the coronary artery bypass graft surgery trialists collaboration. Lancet 1994; 344: 563-570.
2. Tillisch J, Brunker R, Marshall R et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. New Engl J Med 1986; 14: 884-888.
3. vom Dahal J, Eitzman DT, Al-Aouar ZR et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994; 90: 2356-2366.
4. Di Carli MF, Asgarzadie F, Schelbert HR et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436-3444.
5. Dilsizian V, Bonow R. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87: 1-20.
6. Camici P, Rosen S. Does positron emission tomography contribute to the management of clinical cardiac problems? Eur Heart J 1996; 17: 174-181.
7. Schiller N, Shah P, Crawford Met al. Recommendations for quantitation of the left ventricle by two-dimensional echo-cardiography. J Am Soc Echocard 1989; 2: 358-367.
8. Pierard L, De Landsheere C, Berthe C, Rigo P, Kulbertus H. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-1031.
9. Kuhle W, Porenta G, Huang S-C et al. Quantification of regional myocardial blood flow using N13-ammonia and reoriented dynamic positron emission tomography. Circulation 1992; 86: 1004-1017.
10. Gropler RJ, Geltman EM, Sampatukumaran K et al. Comparison of carbon-ll-acetate with fluorine-18-fluorodeoxy-glucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993; 22: 1587-1597.
11. Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994; 23: 851-859.
12. Baer F, Voth E, Deutsch H, Schneider C, Schicha H, Sech-tem U. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 1994; 24: 343-353.
13. Baer F, Voth E, Schneider C, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with F18-fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation 1995; 91: 1006-1015.
14. Lucignani G, Landoni C, Mengozzi G et al. Relation between dobutamine trans-thoracic echocardiography, “Tcm and 18FDG uptake in chronic coronary artery disease. Nucl Med Commun 1995; 16: 548-555.
15. Grandin C, Wijns W, Melin JA et al. Delineation of myocardial viability by PET. J Nucl Med 1995; 36: 1543-1552.
16. Gerber BL, Vanovershelde JJ, Bol A et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996; 94: 651-659.
17. Marinho NVS, Keogh BE, Lammertsma A A, Costa D, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction: New insight from the measurement of regional myocardial blood flow and glucose utilization. Circulation 1996; 93: 737-744.
18. Maisey MN, Hawkes DJ, Lukawiecki-Vydelingum AM. Synergistic imaging. Eur J Nucl Med 1992; 19: 1002-1005.
19. Porenta G, Kuhle W, Czernin J et al. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med 1993; 33: 1623-1631.
20. Savi A, Gilardi MC, Rizzo G et al. Spatial registration of echocardiographic and positron emission tomographic heart studies. Eur J Nucl Med 1995; 22: 243-247.
21. Arnese M, Cornel JH, Salustri A et al. Prediction of improvement of regional left ventricular function after surgical revascularization: A comparison of low-dose dobutamine echocardiography with 201T1 single-photon emission computed tomography. Circulation 1995; 91: 2748-2752.
22. Leoncini M, Marcucci G, Magni M et al. Mycocardial Tc-99m-sestamibi uptake changes during low-dose dobutamine test in asynergic vascular territories. G Ital Cardiol 1996; 26: 1243-1255.
23. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Loren-zoni R, Camici PG. Predictive value of dobutamine echo-cardiography and positron emission tomography in identifying hibernating myocardium in patients with post-ischaemic heart failure. Heart 1998; 79: 281-288.